Financial
Review,
4 September 2023:
Hundreds
of pharmacists were in Canberra for a protest on Monday morning, and
many pharmacists attended question time in white uniforms, jeering as
Prime Minister Anthony Albanese defended Labor’s consultation over
the plan.
In
an already rowdy question time, Speaker of the House of
Representatives Milton Dick warned people in public galleries that
they were present as observers, not participants, in parliamentary
proceedings and should refrain from interjecting.
But
hostilities escalated dramatically when members of the group loudly
exited the chamber, with many yelling at MPs on the chamber floor
below in a co-ordinated exit.
Some
shouted “lies” and at least one pharmacist raised his middle
fingers as he walked out. The sitting was disrupted for a few
minutes…..
Pharmacists
leaving House of Representatives visitor's gallery after disrupting
Question Time and also allegedly abusing Parliament House staff. IMAGE: Canberra Times
MPs
on the Opposition benches in the House of Representatives cat calling & encouraging
pharmacists in the Visitor's Gallery during Question Time on 4
September 2023. It is believed that some of the pharmacists were
signed in as visitors by one or more Liberal Party MPs. IMAGE: Daily Mail
Because
the industry union, Pharmacy Guild of Australia, has run such
a virulent campaign against the the federal government’s reduction
of prescription medicine costs to eligible consumer/patients via the
introduction of 60-day prescriptions for certain medicines
and because Liberal & Nationals members of federal parliament are
attempting to turn this issue into a political football, there may be
a need to restate what the 60-day prescription scheme entails.
Australian
Government, Dept. of
Health and Aged Care, 4
September 2023:
60-day
prescriptions of PBS medicines
Learn
about the changes to Pharmaceutical Benefits Scheme (PBS) medicine
prescriptions.
From
1 September 2023, nearly 100 common medicines listed on the
Pharmaceutical Benefits Scheme (PBS) will have the option of a 60-day
prescription. This means many patients can now receive twice
the medication for the cost of a single prescription. To qualify,
patients must be:
living
with an ongoing health condition
assessed
by their prescriber to be stable on their current medicine/medicines
have
discussed with their prescriber and obtained a new prescription for
a 60-day quantity of medicine per dispensing.
The
changes are happening in 3 stages over 12 months and will apply to
more than 300 medicines once completed on 1 September 2024.
The
changes follow advice from the independent Pharmaceutical Benefits
Advisory Committee (PBAC), which recommended it was clinically safe
and suitable to allow 60-day prescriptions for eligible patients.
The
full list of PBS medicines recommended by PBAC as suitable for
dispensing in increased quantities includes some medicines for
ongoing health conditions, such as:
The
full list of medicines recommended by the PBAC for 60-day
prescribing is available on the medicine
list for increased dispensing quantities.
Prescribers
have the option to prescribe these medicines for either 30 or 60-day
prescriptions, according to their professional clinical judgement.
Benefits
and cost savings
Patients
with a 60-day prescription for a PBS medicine may save up to:
$180
a year, per medicine for Medicare card holders who do not have
a concession card
$43.80
a year, per medicine
for concession cardholders….
Stage
one – available from 1 September 2023
The
first stage of medicines available for 60-day prescriptions will
support patients stable on their current treatment and living with
ongoing health conditions including:
cardiovascular
disease
Crohn’s
disease
gout
heart
failure
high
cholesterol
hypertension
osteoporosis
ulcerative
colitis.
Stage
one includes nearly 100 medicines and represents roughly one third of
all the medicines available for 60-day prescriptions.
See
the list
of stage one medicines. The Department is finalising the order of
medicines available in stage 2 and 3.
Medicine
supply
The
move to 60-day prescriptions won’t cause medicine shortages as
patients will still buy the same amount of medicine annually. While
eligible patients are able to buy double the medication on a single
prescription, demand for medicines will remain unchanged.
Of
the more than 300 medicines PBAC recommended for 60-day
prescriptions, the vast majority have no shortage of supply in
Australia. The Department is monitoring the 60-day dispensing
medicine list and has ensured that medicines
were only included in stage one if they were not in shortage or at
risk of shortage.
Medicine
shortages can occur for different reasons, like:
shortages
of raw material
transport
issues
factory
quality control issues
temporary
factory closures
natural
disasters.
Most
shortages are short-term, temporary disruptions and often only limit
some brands, strengths or formulations.
The
introduction of 60-day prescriptions in three stages over 12 months
reduces pharmacy disruption and let’s supply chains adapt, as
eligible patients will use existing prescriptions first.
Helping
to ensure good medicine supply
Pharmaceutical
companies must tell the Therapeutic Goods Administration (TGA) of
expected medicine
shortages. This means any medicine supply not likely to meet
normal or projected consumer demand at any point during the next 6
months.
The
Australian Government has made changes to the Medicines
Supply Security Guarantee. From 1 July 2023, medicine
manufacturers must have more onshore stockholdings for chosen brands.
This will help make sure there is stock onshore, ready for pharmacy
delivery to meet any temporary increase in demand.
Wholesalers
must deliver to any pharmacy in 24 hours (excluding weekends or
public holidays) if they are running low on medicine. This applies
for most medicines.
Reinvestments
into pharmacy services
The
government commits to supporting a thriving community pharmacy
sector.
All
money saved by the government from reductions in fees paid to
pharmacy for supplying medication to patients will be reinvested into
community pharmacy.
This
is to support the ongoing vital role of the pharmacy sector and give
new opportunities for expanding pharmacists scope of practice.
Note: All yellow highlighting is mine.
Read
the full advice at:
https://www.health.gov.au/our-work/60-day-prescriptions